McLerran, Dale <br/><br/>
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.  [electronic resource] 

 -  Clinical chemistry  Jan 2008 
 - 53-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0009-9147 
<br/><br/><label>Standard No.: </label>10.1373/clinchem.2007.091496  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Aged<br/>Aged, 80 and over<br/>Bias<br/>Biomarkers, Tumor--blood<br/>Blood Specimen Collection<br/>Case-Control Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--diagnosis<br/>Proteomics<br/>Retrospective Studies<br/>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization